Krida Jaringan Nusantara Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Krida Jaringan Nusantara Tbk trades at Rp122 (market cap 61.5B, 7.21M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 9.4× Krida Jaringan Nusantara Tbk's market cap, and Krida Jaringan Nusantara Tbk is more actively traded (7.21M versus 3.48M). Which is the better fit depends on your goals.
| KJEN | LABS | |
|---|---|---|
Market Cap | 61.5B | 576.7B |
Volume | 7.21M | 3.48M |
Lot | 72.09K | 34.82K |
Turnover | 878.11M | 522.79M |
Average Price | 121.8 | 150.13 |
Value | 878.11M | 522.79M |
Indicative Equilibrium Price | 122 | 148 |
Indicative Equilibrium Volume | 307 | 350 |
Trailing returns across standard periods
Latest headlines on both assets
PT Krida Jaringan Nusantara Tbk (the Company) was established in Jakarta based on the NotarialDeed No. 5 dated October 1, 1998 of Saal Bumela, S.H., Notary in Jakarta.
Read more on KJEN →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →